Be the first to like this
Merck is one of the world’s biggest drugmakers and is a staple in dividend investors’ portfolios. That’s because drugmakers like Merck offer investors a steady (and predictable) stream of dividend boosting revenue. But investors are right to wonder if Merck’s dividend is on solid footing given the patent cliff has taken a toll on its sales.
Clipping is a handy way to collect important slides you want to go back to later.